ETNB: 89bio, Inc. Stock

by  •  • Comments Off on ETNB: 89bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 729.19
Enterprise Value ($M) 638.86
Book Value ($M) 400.79
Book Value / Share 2.75
Price / Book 1.82
NCAV ($M) 398.55
NCAV / Share 2.73
Price / NCAV 1.83

Profitability (mra)
Return on Invested Capital (ROIC) -0.84
Return on Assets (ROA) -0.64
Return on Equity (ROE) -0.72

Liquidity (mrq)
Quick Ratio 13.19
Current Ratio 13.19

Balance Sheet (mrq) ($M)
Current Assets 476.45
Assets 478.69
Liabilities 77.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -384.66
Net Income -367.08

Cash Flow Statement (mra) ($M)
Cash From Operations -367.82
Cash from Investing -40.86
Cash from Financing 218.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-03 13D/A Ra Capital Management, L.p. 13.70 0.00
02-14 13G/A Biotechnology Value Fund L P 3.60 -36.38
02-13 13G/A Suvretta Capital Management, Llc 8.50 27.67
02-07 13G/A Janus Henderson Group Plc 15.30 717.38
12-23 13G Deep Track Capital, LP 5.41 223.90
11-14 13G/A Rtw Investments, Lp 7.00 32.26
11-08 13G/A BlackRock, Inc. 7.10 0.00
10-17 13G/A State Street Corp 3.10 -39.78

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 312,299 1,653,745 18.88
2025-04-10 356,321 2,022,045 17.62
2025-04-09 655,368 3,989,109 16.43
2025-04-08 510,534 2,112,137 24.17
2025-04-07 873,428 2,842,366 30.73

(click for more detail)

Similar Companies
CVAC – CureVac N.V. EOLS – Evolus, Inc.
ESPR – Esperion Therapeutics, Inc. ETON – Eton Pharmaceuticals, Inc.
FATE – Fate Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io